Use of microarray analysis to investigate EMT gene signatures

Methods in Molecular Biology

Volumn 1046, Issue , 2013, Pages 85-95

  Sims, Andrew H ^a   Larionov, Alexey A ^a   Harrison, David J ^b   Katz, Elad ^c  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

^c AMS Biotechnology   (United Kingdom)

Author keywords

Epithelium; Gene expression signature; Mesenchyme; Microarrays; Transcriptomic profiles

Indexed keywords

ARTICLE; CELL ADHESION; CELL MOTILITY; DEFENSE MECHANISM; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; RNA EXTRACTION;

EID: 84934442517     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-538-5_5     Document Type: Article

References (42)

1. Katz E, Dubois-Marshall S, Sims AH, Gautier P, Caldwell H, Meehan RR, Harrison DJ (2011) An in vitro model that recapitulates the Epithelial to Mesenchymal Transition (EMT) in human breast cancer. PLoS One 6:e17083
2. Arendt LM, Rudnick JA, Keller PJ, Kuperwasser C (2010) Stroma in breast development and disease. Semin Cell Dev Biol 21:11-18
3. Weigelt B, Peterse JL, van't Veer LJ (2005) Breast cancer metastasis: Markers and models. Nat Rev Cancer 5:591-602
4. Thiery JP (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15:740-746
5. Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131-142
6. Polyak K, Weinberg RA (2009) Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer 9:265-273
7. Huber MA, Kraut N, Beug H (2005) Molecular requirements for epithelialmesenchymal transition during tumor progression. Curr Opin Cell Biol 17:548-558
8. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, Lander ES (2009) Identifi cation of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138:645-659
9. Schmalhofer O, Brabletz S, Brabletz T (2009) E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 28:151-166
10. Hazan RB, Qiao R, Keren R, Badano I, Suyama K (2004) Cadherin switch in tumor progression. Ann N Y Acad Sci 1014: 155-163
11. Peinado H, Olmeda D, Cano A (2007) Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nat Rev Cancer 7:415-428
12. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA (2000) Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148:779-790
13. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ (1999) N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147:631-644
14. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP et al (2007) Identifi cation of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol 8:R76
15. Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A, Rimm DL, Wong H et al (2009) Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA 106:13820-13825
16. Hennessy BT, Gonzalez-Angulo AM, Stemke- Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS, Fridlyand J, Sahin A et al (2009) Characterization of a naturally occurring breast cancer subset enriched in epithelial-tomesenchymal transition and stem cell characteristics. Cancer Res 69:4116-4124
17. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM (2010) Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res 12:R68
18. Katz E, Dubois-Marshall S, Sims AH, Faratian D, Li J, Smith ES, Quinn JA, Edward M et al (2010) A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of Syk. Br J Cancer 103:401-410
19. Katz E, Sims AH, Sproul D, Caldwell H, Dixon MJ, Meehan RR, Harrison DJ (2012) Targeting of Rac GTPases blocks the spread of intact human breast cancer. Oncotarget 3: 608-619
20. Leeper AD, Farrell J, Williams LJ, Thomas JS, Dixon JM, Wedden SE, Harrison DJ, Katz E (2012) Determining tamoxifen sensitivity using primary breast cancer tissue in collagenbased three-dimensional culture. Biomaterials 33:907-915
21. Brazma A, Kapushesky M, Parkinson H, Sarkans U, Shojatalab M (2006) Data storage and analysis in ArrayExpress. Methods Enzymol 411:370-386
22. Barrett T, Suzek TO, Troup DB, Wilhite SE, Ngau WC, Ledoux P, Rudnev D, Lash AE et al (2005) NCBI GEO: Mining millions of expression profi les-database and tools. Nucleic Acids Res 33:D562-D566
23. da Huang W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57
24. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L et al (2004) Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 5:R80
25. Tusher VG, Tibshirani R, Chu G (2001) Signifi cance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121
26. Dai M, Wang P, Boyd AD, Kostov G, Athey B, Jones EG, Bunney WE, Myers RM et al (2005) Evolving gene/transcript defi nitions signifi - cantly alter the interpretation of GeneChip data. Nucleic Acids Res 33:e175
27. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264
28. Johnson WE, Li C, Rabinovic A (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8:118-127
29. Sims AH, Smethurst GJ, Hey Y, Okoniewski MJ, Pepper SD, Howell A, Miller CJ, Clarke RB (2008) The removal of multiplicative, systematic bias allows integration of breast cancer gene expression datasets - improving metaanalysis and prediction of prognosis. BMC Med Genomics 1:42
30. Kitchen RR, Sabine VS, Simen AA, Dixon JM, Bartlett JM, Sims AH (2011) Relative impact of key sources of systematic noise in Affymetrix and Illumina gene-expression microarray experiments. BMC Genomics 12:589
31. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868
32. Gautier L, Cope L, Bolstad BM, Irizarry RA (2004) affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 20: 307-315
33. Smyth GK, Michaud J, Scott HS (2005) Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 21:2067-2075
34. Dunning MJ, Smith ML, Ritchie ME, Tavare S (2007) beadarray: R classes and methods for Illumina bead-based data. Bioinformatics 23:2183-2184
35. Du P, Kibbe WA, Lin SM (2008) Lumi: A pipeline for processing Illumina microarray. Bioinformatics 24:1547-1548
36. Clarke R, Ressom HW, Wang A, Xuan J, Liu MC, Gehan EA, Wang Y (2008) The properties of high-dimensional data spaces: Implications for exploring gene and protein expression data. Nat Rev Cancer 8:37-49
37. Breitling R, Armengaud P, Amtmann A, Herzyk P (2004) Rank products: A simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett 573:83-92
38. Zeeberg BR, Qin H, Narasimhan S, Sunshine M, Cao H, Kane DW, Reimers M, Stephens RM et al (2005) High-Throughput GoMiner, an 'industrial-strength' integrative gene ontology tool for interpretation of multiplemicroarray experiments, with application to studies of Common Variable Immune Defi ciency (CVID). BMC Bioinformatics 6:168
39. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL et al (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profi les. Proc Natl Acad Sci USA 102:15545-15550
40. Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J, Hartwell K, Onder TT et al (2010) Core epithelial-tomesenchymal transition interactome geneexpression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA 107: 15449-15454
41. Yilmaz M, Christofori G (2010) Mechanisms of motility in metastasizing cells. Mol Cancer Res 8:629-642
42. Sims AH (2009) Bioinformatics and breast cancer: What can high-throughput genomic approaches actually tell us? J Clin Pathol 62:879-885